Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FVW71
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,862
Award facts
- Contract value 100% obligated
- $18,861.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,861.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of XGEVA 120 mg/1.7 mL vials. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management (SAM.gov). This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which extends through December 2026.
The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related healthcare supplies across multiple therapeutic domains. This delivery order for XGEVA, a bone health medication commonly used in oncology and orthopedic applications, demonstrates AmerisourceBergen's role in fulfilling the Defense Health Agency's pharmaceutical supply requirements through the DLA's Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DB25FVW71?
SPE2DB25FVW71 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FVW71 worth?
The government has obligated $18,862 on SPE2DB25FVW71.
Is contract SPE2DB25FVW71 an order under another contract?
Yes. SPE2DB25FVW71 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FVW71 competed?
The extent of competition for SPE2DB25FVW71 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award